Return to study ST002863 main page

Download data matrix(Metabolic profiling and glucose tracing in naive and Enzalutamide-treated 16D prostate cancer cells HILIC UNSPECIFIED ION MODE)

AnalysisSamplesFactorsUnits
HILIC UNSPECIFIED ION MODEJG-004Treatment:Enzalutamide 24 hoursAbundance
HILIC UNSPECIFIED ION MODEJG-005Treatment:Enzalutamide 24 hoursAbundance
HILIC UNSPECIFIED ION MODEJG-006Treatment:Enzalutamide 24 hoursAbundance
HILIC UNSPECIFIED ION MODEJG-007Treatment:Enzalutamide 48 hoursAbundance
HILIC UNSPECIFIED ION MODEJG-008Treatment:Enzalutamide 48 hoursAbundance
HILIC UNSPECIFIED ION MODEJG-009Treatment:Enzalutamide 48 hoursAbundance
HILIC UNSPECIFIED ION MODEJG-010Treatment:Enzalutamide long-termAbundance
HILIC UNSPECIFIED ION MODEJG-011Treatment:Enzalutamide long-termAbundance
HILIC UNSPECIFIED ION MODEJG-012Treatment:Enzalutamide long-termAbundance
HILIC UNSPECIFIED ION MODEQC-blank1Treatment:NAAbundance
HILIC UNSPECIFIED ION MODEQC-blank2Treatment:NAAbundance
HILIC UNSPECIFIED ION MODEJG-001Treatment:vehicle (DMSO)Abundance
HILIC UNSPECIFIED ION MODEJG-002Treatment:vehicle (DMSO)Abundance
HILIC UNSPECIFIED ION MODEJG-003Treatment:vehicle (DMSO)Abundance
  logo